A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study

NCT02653443 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Autologous apheresis Platelet Components, prepared with the INTERCEPT Blood System for Platelets.
BIOLOGICAL: Autologous apheresis Conventional untreated Platelet Components

Sponsor

Cerus Corporation